Kim Kelderman Bio Techne Corp (TECH) insider trading activity

TECH Quotes by TradingView

Kim Kelderman is Chief Executive Officer of BIO-TECHNE Corp. Currently has a direct ownership of 39,004 shares of TECH, which is worth approximately $2.85 Million. The most recent transaction as insider was on Nov 01, 2024, when has been sold 2,430 shares (Common Stock) at a price of $75.31 per share, resulting in proceeds of $183,003. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 39K
5.86% 3M change
10.12% 12M change
Total Value Held $2.85 Million

Kim Kelderman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 01 2024
SELL
Payment of exercise price or tax liability
$183,003 $75.31 p/Share
2,430 Reduced 5.86%
39,004 Common Stock
Aug 29 2024
BUY
Exercise of conversion of derivative security
$99,919 $66.97 p/Share
1,492 Added 3.48%
41,434 Common Stock
Jul 31 2024
SELL
Payment of exercise price or tax liability
$776,993 $81.97 p/Share
9,479 Reduced 19.18%
39,942 Common Stock
Jul 31 2024
BUY
Exercise of conversion of derivative security
$527,800 $37.7 p/Share
14,000 Added 22.07%
49,421 Common Stock
Nov 01 2023
BUY
Grant, award, or other acquisition
-
14,196 Added 28.61%
35,421 Common Stock
Aug 24 2023
BUY
Exercise of conversion of derivative security
$99,960 $47.6 p/Share
2,100 Added 9.0%
21,225 Common Stock
Aug 05 2023
SELL
Payment of exercise price or tax liability
$340,101 $82.17 p/Share
4,139 Reduced 17.79%
19,125 Common Stock
Aug 05 2023
BUY
Exercise of conversion of derivative security
-
8,060 Added 25.73%
23,264 Common Stock
Aug 23 2022
BUY
Exercise of conversion of derivative security
$99,967 $150.78 p/Share
663 Added 14.85%
3,801 Common Stock
Aug 07 2022
SELL
Payment of exercise price or tax liability
$464,926 $382.97 p/Share
1,214 Reduced 27.9%
3,138 Common Stock
Aug 07 2022
BUY
Exercise of conversion of derivative security
-
2,363 Added 35.19%
4,352 Common Stock
Feb 08 2022
BUY
Exercise of conversion of derivative security
$299,901 $150.78 p/Share
1,989 Added 50.0%
1,989 Common Stock
Nov 19 2021
SELL
Open market or private sale
$252,385 $504.77 p/Share
500 Reduced 100.0%
0 Common Stock
Nov 19 2021
BUY
Exercise of conversion of derivative security
$75,390 $150.78 p/Share
500 Added 50.0%
500 Common Stock
Sep 22 2021
SELL
Open market or private sale
$434,871 $529.04 p/Share
822 Reduced 100.0%
0 Common Stock
Aug 08 2021
SELL
Payment of exercise price or tax liability
$418,702 $481.82 p/Share
869 Reduced 51.39%
822 Common Stock
Aug 08 2021
BUY
Exercise of conversion of derivative security
-
1,691 Added 50.0%
1,691 Common Stock
Jun 09 2021
SELL
Open market or private sale
$351,163 $433.0 p/Share
811 Reduced 100.0%
0 Common Stock
May 25 2021
SELL
Open market or private sale
$358,280 $424.0 p/Share
845 Reduced 51.03%
811 Common Stock
May 01 2021
SELL
Payment of exercise price or tax liability
$365,931 $427.49 p/Share
856 Reduced 34.08%
1,656 Common Stock
May 01 2021
BUY
Exercise of conversion of derivative security
-
1,667 Added 39.89%
2,512 Common Stock
Feb 05 2021
SELL
Open market or private sale
$319,694 $388.45 p/Share
823 Reduced 49.34%
845 Common Stock
KK

Kim Kelderman

Chief Executive Officer
Minneapolis, MN

Track Institutional and Insider Activities on TECH

Follow BIO-TECHNE Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TECH shares.

Notify only if

Insider Trading

Get notified when an Bio Techne Corp insider buys or sells TECH shares.

Notify only if

News

Receive news related to BIO-TECHNE Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TECH